Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and ...

Biohaven (NYSE:BHVN) stock gains on tumor-shrinking results for the company's cancer drug BHV-1510 with Regeneron's (REGN) ...

Fintel reports that on May 19, 2025, RBC Capital downgraded their outlook for Biohaven (NYSE:BHVN) from Outperform to Sector ...

Biohaven (BHVN) stock slides as the FDA delays review of its lead drug troriluzole for a neurological condition called ...

In this article, we are going to take a look at where Biohaven Ltd. (NYSE:BHVN) stands against the other stocks that will bounce back. Major US indexes finished in the green on Wednesday ...

NEW YORK, May 26, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN). Such investors are advised to ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Biohaven Ltd (Symbol: BHVN), where a total volume of 12,755 contracts has been ...

Morgan Stanley analyst Terence Flynn reiterated a Buy rating on Biohaven Ltd. (BHVN – Research Report) today and set a price target of $63.00. The company’s shares closed yest ...

BIOHAVEN ($BHVN) is expected to release its quarterly earnings data on Friday, May 9th before market open, per Finnhub. Analysts are expecting revenue of $1,416,667 ...

RBC Capital analyst Leonid Timashev maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report) yesterday and set a price target of $54.00. The company’s shares closed y ...

In this article, we are going to take a look at where Biohaven Ltd. (NYSE:BHVN) stands against the other stocks that will bounce back. Major US indexes finished in the green on Wednesday, May 7, after ...